The American Heart Association recently raised the bar on the timely treatment of acute ischemic stroke (AIS) with intravenous alteplase. Our study looks at the effectiveness of this new standard, by examining the effect of varying door-to-needle times of alteplase initiation on the clinical, quality of care, and efficiency of care outcomes.

中文翻译：

---

阿替普酶给药 30 分钟上门时间标准的有益效果

美国心脏协会最近提高了静脉阿替普酶及时治疗急性缺血性卒中 (AIS) 的标准。我们的研究通过检查不同的阿替普酶起始时间对临床、护理质量和护理结果效率的影响，着眼于这一新标准的有效性。